期刊文献+

肺腺癌细胞中EGFR蛋白的表达与细胞内胶原化的相关性研究

Correlation between protein expression of epidermal growth factor receptors and intra-cellular matrix collagenation in lung adenocarcinoma cells
下载PDF
导出
摘要 目的探讨表皮生长因子受体(epidermal growth factor receptor,EGFR)在肺腺癌细胞中的表达及与细胞发生胶原化的相关性。方法从胸水中提取肺腺癌细胞为研究对象,以32例良性胸水中的增生上皮细胞、炎性细胞为对照,采用免疫细胞化学方法检测细胞中EGFR、E钙粘素蛋白、Vimentin、TTF-1和胶原蛋白亚型I的表达。Masson染色方法检测胶原纤维表达。结果 78例胸水标本中,EGFR在肺腺癌细胞中的阳性率为79.5%,胶原蛋白亚型I为32.1%,Masson染色的阳性率为70.5%,明显高于对照组且EGFR和Masson染色的阳性表达结果的相关性具有统计学意义(P<0.01)。结论 EG-FR在肺腺癌细胞中阳性表达,可能与细胞内基质胶原蛋白形成有关。 ] Objective To investigate the clinical significance of the relationship between EGFR (epidermal growth factor receptor) and intra-cellular matrix collagenation in lung adenocarcinoma cells. Methods Lung adenocarcinoma cells were obtained. 32 cases of hyperplasia epithelial cells of non-malignant pleural effusion were obtained as control. Immunocytoehemiscal staining was used to test EGFR, E- cadherin, Vimentin, TTF-1 and Collagen I. Collagen was analyzed by Masson staining. Results EGFR positive expression was found in 62 of 78 (79. 5%) cases of malignant pleural effusion. Positive rate of Collagen I and Masson staining was 32. 1% and 70.5%. Our data showed that elevated levels of EGFR were accompanied by collagen expression in lung adenocarcinoma cells. Hyperplasia epithelial cells from non-malignant pleural fluid were uniformly negative for EGFR. Conclusion Our study shows EGFR positive expression in lung adenocarcinoma cells may be related to collagen formation in the cytoplasm.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2013年第1期71-74,共4页 Chinese Journal of Histochemistry and Cytochemistry
基金 中国博士后科学基金资助(20060390301) 国家自然科学基金资助(30600341)
关键词 表皮生长因子受体 上皮间质转化 肺腺癌细胞 胸水 Epidermal growth factor receptor EMT Lung adenocarcinoma cell Pleural effusion
  • 相关文献

参考文献7

二级参考文献93

  • 1石艳华,叶红,关丽华,申兴斌,龚秀云,王瑞婷.大肠正常粘膜、腺瘤及癌组织中VEGF及其受体Flk-1表达的意义[J].河北医药,2007,29(2):107-108. 被引量:4
  • 2Saito H, Tsujitani S, Kondo A, et al. Tumor vascularity as a prognostic factor in cancer patients. Surgery, 1999,125:195.
  • 3Yonemura Y, Fushida S, Bando E, et al. Lymph angiogenesis and the vascular endothelial growth factor receptor(VEGFR) ingastric cance. Eur J Cancer, 2001,37: 918-923.
  • 4Kinoshita J, Kitamura K, Kabashima A, et al. Clinical significance of vascular endothelial growth factor C (VEGF-C) in breast cancer. Breast Cancer Res Treat, 2001,66:159-164.
  • 5Habets GG, Schohes EH, Zuydgeest D, et al. Indentification of an in-vasioninducing gene, Tiaml, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell, 1994,77 : 537-549.
  • 6Semenza GL, Agani F, Feldser D, et al. HyPoxia, HIF, and the Patho Physiology of common human diseases. Adv ExP Med Biol,2000,475:123-130.
  • 7Weidner N, Folkman J, Pozza F, et al. Tumor angiogensis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst, 1992,84:1875-1881.
  • 8DU J, Zhang L. Expression and clinieopathological significance of Tiaml in non-small cell lung cancer. Journal China Medical Univercity, 2005,4: 329- 331.
  • 9Shimanuki Y,Takahashi K, Cui R, et al. Role of senan vascular endothelial growth factor in the prediction ofangiogenesis and prognosis for non-small cell lung cancer, Lung, 2005,183 : 29-42.
  • 10Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am Jphysiol Lung Cell Mol Physiol, 2006,290 : 209-221.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部